Cargando…
LRRK2 in Parkinson's disease – drawing the curtain of penetrance: a commentary
Parkinson's disease is the most common neurodegenerative movement disorder and affects about 2% of the population over the age of 60 years. In 2004, mutations in the LRRK2 gene were first described and turned out to be the most frequent genetic cause of familial and sporadic Parkinson's di...
Autor principal: | Krüger, Rejko |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2607298/ https://www.ncbi.nlm.nih.gov/pubmed/18986509 http://dx.doi.org/10.1186/1741-7015-6-33 |
Ejemplares similares
-
‘Drawing aside the curtain’: natural childbirth on screen in 1950s Britain
por: AL-GAILANI, SALIM
Publicado: (2017) -
LRRK2-NFATc2 Pathway Associated with Neuroinflammation May Be a Potential Therapeutic Target for Parkinson’s Disease
por: Wang, Youcui, et al.
Publicado: (2021) -
Behind the curtain: Workplace violence against nurses in Pakistan
por: Khan, Imaan Ghalib, et al.
Publicado: (2022) -
Back to the future: new target-validated Rab antibodies for evaluating LRRK2 signalling in cell biology and Parkinson's disease
por: Eyers, Patrick A.
Publicado: (2018) -
‘Up with the LRRK’: a phosphorylated Rab10 assay for evaluation of LRRK2 activity and inhibitor engagement
por: Eyers, Patrick A.
Publicado: (2016)